Implantable medical devices have been implemented to provide treatment and to assess in
vivo physiological information in humans as well as animal models for medical diagnosis …

Stimulus-responsive materials are able to response to a particular stimulus, such as, heat,
chemical, and light. As such, they are smarter and more intelligent than ordinary materials …

Fully bioresorbable scaffolds (BRS) were designed to overcome the limitations of metallic
drug-eluting stents, which permanently cage the vessel wall, thereby preventing normal …

Background Preliminary reports of studies involving simple coronary lesions indicate that a
sirolimus-eluting stent significantly reduces the risk of restenosis after percutaneous …

Background The need for repeated treatment of restenosis of a treated vessel remains the
main limitation of percutaneous coronary revascularization. Because sirolimus (rapamycin) …

Background—The US Food and Drug Administration recently issued a warning of subacute
thrombosis and hypersensitivity reactions to sirolimus-eluting stents (Cypher). The cause …

Coronary artery stents revolutionized the practice of interventional cardiology after they were
first introduced in the mid-1980s. Since then, there have been significant developments in …

Gruntzig in 1977 was a huge leap forward in cardiovascular medicine and undoubtedly will
always be remembered as a revolution in the field of revascularization. However, this …

The ACC/AHA Task Force on Practice Guidelines was formed to gather information and
make recommendations about appropriate use of technology for the diagnosis and …

Objectives: We sought to define the incidence of late clinical events and late stent
thrombosis in patients treated with drug-eluting (DES) versus bare-metal stents (BMS) after …